Sean Collins
Articles
-
Mar 18, 2024 |
urologytimes.com | Brian Helfand |Brian F. Chapin |Sean Collins
Future Horizons in PSMA-Targeted Imaging and the Management of Prostate CancerExperts close their discussion by highlighting the future landscape of PSMA-targeted imaging in the management of prostate cancer.
-
Mar 11, 2024 |
urologytimes.com | Brian Helfand |Brian F. Chapin |Sean Collins
Drs Helfand, Chapin, and Collins, review the case of 67-year-old man treated with recurring prostate cancer.
-
Mar 11, 2024 |
urologytimes.com | Brian Helfand |Brian F. Chapin |Sean Collins
Clinical oncologists present the case of a 62-year-old man with recurrent prostate cancer.
-
Mar 4, 2024 |
urologytimes.com | Brian Helfand |Brian F. Chapin |Sean Collins
An Overview of the SPOTLIGHT Trial for PSMA PET in Prostate CancerA panel of expert oncologists review clinical cases and provide a comprehensive discussion on the recent clinical advances in PSMA PET imaging for prostate cancer.
-
Mar 4, 2024 |
urologytimes.com | Brian Helfand |Brian F. Chapin |Sean Collins
Experts in prostate cancer evaluate the data from the SPOTLIGHT trial and the use of 18F-rhPSMA-7.3 for prostate cancer.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →